IMAC HOLDINGS INC (BACK) Stock Price, Forecast & Analysis
USA - NASDAQ:BACK - US44967K3023 - Common Stock
BACK Key Statistics, Chart & Performance
The current stock price of BACK is 0.2 USD. In the past month the price decreased by -67.02%. In the past year, price decreased by -93.46%.
BACK Latest News, Press Relases and Analysis
BACK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 18.41 | 111.44B | ||
| THC | TENET HEALTHCARE CORP | 12.03 | 16.49B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.84 | 14.34B | ||
| EHC | ENCOMPASS HEALTH CORP | 21.82 | 11.36B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.74 | 10.35B | ||
| PACS | PACS GROUP INC | 34.39 | 4.06B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.49B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.57 | 2.49B | ||
| SGRY | SURGERY PARTNERS INC | 19.62 | 1.96B | ||
| NHC | NATIONAL HEALTHCARE CORP | 18.98 | 1.97B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 15.12 | 1.61B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 5.54 | 1.33B |
Related stock screener links
About BACK
Company Profile
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Franklin, Tennessee and currently employs 2 full-time employees. The company went IPO on 2019-02-13. The firm is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The firm is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The firm is also engaged in providing the precision medicine business. The firm's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
Company Info
IMAC HOLDINGS INC
3401 Mallory Lane, Suite 100
Franklin TENNESSEE US
Employees: 3
Phone: 18442664622
IMAC HOLDINGS INC / BACK FAQ
Can you describe the business of IMAC HOLDINGS INC?
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Franklin, Tennessee and currently employs 2 full-time employees. The company went IPO on 2019-02-13. The firm is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The firm is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The firm is also engaged in providing the precision medicine business. The firm's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDTs are utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
What is the stock price of IMAC HOLDINGS INC today?
The current stock price of BACK is 0.2 USD. The price decreased by -52.65% in the last trading session.
Does BACK stock pay dividends?
BACK does not pay a dividend.
What is the ChartMill technical and fundamental rating of BACK stock?
BACK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What do analysts say about IMAC HOLDINGS INC (BACK) stock?
7 analysts have analysed BACK and the average price target is 8.41 USD. This implies a price increase of 4107.5% is expected in the next year compared to the current price of 0.2.
What is IMAC HOLDINGS INC worth?
IMAC HOLDINGS INC (BACK) has a market capitalization of 674.00K USD. This makes BACK a Nano Cap stock.
What is the next earnings date for BACK stock?
IMAC HOLDINGS INC (BACK) will report earnings on 2025-04-14.
BACK Technical Analysis
BACK Financial Highlights
Over the last trailing twelve months BACK reported a non-GAAP Earnings per Share(EPS) of -4.76. The EPS increased by 66.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -993.1% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BACK Forecast & Estimates
7 analysts have analysed BACK and the average price target is 8.41 USD. This implies a price increase of 4107.5% is expected in the next year compared to the current price of 0.2.
For the next year, analysts expect an EPS growth of 69.42% and a revenue growth -100% for BACK